Stereotactic Radiosurgery for Resected Brain Metastases: Single-Institutional Experience of Over 500 Cavities

被引:45
作者
Shi, Siyu [1 ]
Sandhu, Navjot [1 ]
Jin, Michael C. [1 ]
Wang, Elyn [1 ]
Jaoude, Joseph Abi [1 ]
Schofield, Kirsten [1 ]
Zhang, Carrie [1 ]
Liu, Elisa [1 ]
Gibbs, Iris C. [1 ]
Hancock, Steven L. [1 ]
Chang, Steven D. [2 ]
Li, Gordon [2 ]
Hayden-Gephart, Melanie [2 ]
Adler, John R. [2 ]
Soltys, Scott G. [1 ]
Pollom, Erqi L. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 04期
关键词
SURGICAL RESECTION; LEPTOMENINGEAL DISEASE; RADIATION-THERAPY; CLINICAL-OUTCOMES; TUMOR BED; RISK; RADIOTHERAPY; RECURRENCE; FAILURE; PROGRESSION;
D O I
10.1016/j.ijrobp.2019.11.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Postoperative stereotactic radiosurgery (SRS) has less detrimental effect on cognition and quality of life compared with whole brain radiation therapy (WBRT) and is increasingly used for resected brain metastases (BMs). Postoperative SRS techniques are not standardized, and there is a concern for a different pattern of failure after postoperative SRS compared with WBRT. We aim to study the efficacy, toxicity, and failure pattern of postoperative SRS. Methods and Materials: We retrospectively reviewed outcomes of patients with resected BMs treated with postoperative SRS between 2007 and 2018. Overall survival and cumulative incidences of local failure, overall distant intracranial failure (distant parenchymal failure, nodular leptomeningeal disease [nLMD], classical leptomeningeal disease [cLMD]), and adverse radiation effect were reported. Neurologic death was determined for patients with leptomeningeal disease (LMD). Results: A total of 442 patients with 501 resected BMs were treated over 475 total SRS courses. Median clinical follow-up and overall survival after SRS were 10.1 months (interquartile range, 3.6-20.7 months) and 13.9 months (95% confidence interval [CI], 11.8-15.2 months), respectively. At 12 months, event rates were 7% (95% CI, 5%-10%) for local failure, 9% (95% CI, 7%-12%) for adverse radiation effect, 44% (95% CI, 40%-49%) for overall distant intracranial failure, 37% (95% CI, 33%-42%) for distant parenchymal failure, and 13% (95% CI, 10%-17%) for LMD. The overall incidence of LMD was 15.8% (53% cLMD, 46% nLMD). cLMD was associated with shorter survival than nLMD (2.0 vs 11.2 months, P < .01) and a higher proportion of neurologic death (67% vs 41%, P = .02). A total of 15% of patients ultimately received WBRT. Conclusions: We report the largest clinical experience of postoperative SRS for resected BMs, showing excellent local control and low toxicity. Intracranial failure was predominantly distant, with a rising incidence of LMD. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:764 / 771
页数:8
相关论文
共 52 条
[1]   Postoperative Stereotactic Radiosurgery Using 5-Gy x 5 Sessions in the Management of Brain Metastases [J].
Abuodeh, Yazan ;
Ahmed, Kamran A. ;
Naghavi, Arash O. ;
Venkat, Puja S. ;
Sarangkasiri, Siriporn ;
Johnstone, Peter A. S. ;
Etame, Arnold B. ;
Yu, Hsiang-Hsuan Michael .
WORLD NEUROSURGERY, 2016, 90 :58-65
[2]  
[Anonymous], NEUROONCOL
[3]  
ARBIT E, 1995, CANCER, V76, P765, DOI 10.1002/1097-0142(19950901)76:5<765::AID-CNCR2820760509>3.0.CO
[4]  
2-E
[5]   Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases [J].
Atalar, Banu ;
Modlin, Leslie A. ;
Choi, Clara Y. H. ;
Adler, John R. ;
Gibbs, Iris C. ;
Chang, Steven D. ;
Harsh, Griffith R. ;
Li, Gordon ;
Nagpal, Seema ;
Hanlon, Alexandra ;
Soltys, Scott G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (04) :713-718
[6]   Cavity Volume Dynamics After Resection of Brain Metastases and Timing of Postresection Cavity Stereotactic Radiosurgery [J].
Atalar, Banu ;
Choi, Clara Y. H. ;
Harsh, Griffith R. ;
Chang, Steven D. ;
Gibbs, Iris C. ;
Adler, John R. ;
Soltys, Scott G. .
NEUROSURGERY, 2013, 72 (02) :180-185
[7]  
Bellamkonda S, 2018, ADULT CNS RAD ONCOLO, P191
[8]   Adjusting for multiple testing - when and how? [J].
Bender, R ;
Lange, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (04) :343-349
[9]   A Phase 2 Trial of Stereotactic Radiosurgery Boost After Surgical Resection for Brain Metastases [J].
Brennan, Cameron ;
Yang, T. Jonathan ;
Hilden, Patrick ;
Zhang, Zhigang ;
Chan, Kelvin ;
Yamada, Yoshiya ;
Chan, Timothy A. ;
Lymberis, Stella C. ;
Narayana, Ashwatha ;
Tabar, Viviane ;
Gutin, Philip H. ;
Ballangrud, Ase ;
Lis, Eric ;
Beal, Kathryn .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (01) :130-136
[10]   Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial [J].
Brown, Paul D. ;
Ballman, Karla V. ;
Cerhan, Jane H. ;
Anderson, S. Keith ;
Carrero, Xiomara W. ;
Whitton, Anthony C. ;
Greenspoon, Jeffrey ;
Parney, Ian F. ;
Laack, Nadia N. I. ;
Ashman, Jonathan B. ;
Bahary, Jean-Paul ;
Hadjipanayis, Costas G. ;
Urbanic, James J. ;
Barker, Fred G., II ;
Farace, Elana ;
Khuntia, Deepak ;
Giannini, Caterina ;
Buckner, Jan C. ;
Galanis, Evanthia ;
Roberge, David .
LANCET ONCOLOGY, 2017, 18 (08) :1049-1060